P. Lissoni
- Co-authors
- Gabriele TanciniSandro BarniFranco RovelliS. BarniLuca FumagalliFabio MaluganiF BrivioG Gardani
- Topics
- Circadian rhythm and melatonin (12 papers)Cancer Immunotherapy and Biomarkers (9 papers)Immunotherapy and Immune Responses (4 papers)
- Partner nations
- ItalySwitzerlandUnited States
In The Last Decade
P. Lissoni
33 papers receiving 455 citations
Peers
Comparison fields: 5 of 77
- Oncology 154
- Immunology 128
- Endocrine and Autonomic Systems 125
- Molecular Biology 99
- Physiology 56
Countries citing papers authored by P. Lissoni
This map shows the geographic impact of P. Lissoni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P. Lissoni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P. Lissoni more than expected).
Fields of papers citing papers by P. Lissoni
This network shows the impact of papers produced by P. Lissoni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P. Lissoni. The network helps show where P. Lissoni may publish in the future.
Co-authorship network of co-authors of P. Lissoni
This figure shows the co-authorship network connecting the top 25 collaborators of P. Lissoni. A scholar is included among the top collaborators of P. Lissoni based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P. Lissoni. P. Lissoni is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 23 | |
| 2 | A phase II study of chemoneuroimmunotherapy with platinum, subcutaneous low-dose interleukin-2 and the pineal neurohormone melatonin (P.I.M.) as a second-line therapy in metastatic melanoma patients progressing on dacarbazine plus interferon-alpha. | 22 |
| 3 | Ten-year survival results in metastatic renal cell cancer patients treated with monoimmunotherapy with subcutaneous low-dose interleukin-2. | 19 |
| 4 | 16 | |
| 5 | Circulating dendritic cells in early and advanced cancer patients: diminished percent in the metastatic disease. | 39 |
| 6 | 12 | |
| 7 | 4 | |
| 8 | 13 | |
| 9 | [Preoperative subcutaneous immunotherapy with interleukin-2 in renal carcinoma with synchronous metastasis: randomized clinico-biological study. Preoperative use of Il-2 in renal carcinoma]. | 0 |
| 10 | 9 | |
| 11 | Prevention of interleukin-2-induced thrombocytopenia during the immunotherapy of cancer by a concomitant administration of the pineal hormone melatonin. | 7 |
| 12 | [Prognostic predictive factors of the clinical response to immunotherapy with subcutaneous interleukin-2, in patients with metastatic renal carcinoma: analysis of 60 cases]. | 2 |
| 13 | 61 | |
| 14 | 27 | |
| 15 | 37 | |
| 16 | 6 | |
| 17 | 4 | |
| 18 | Endocrine effects of a 24-hour intravenous infusion of interleukin-2 in the immunotherapy of cancer. | 24 |
| 19 | 3 | |
| 20 | 5 |
About P. Lissoni
P. Lissoni is a scholar working on Endocrine and Autonomic Systems, Oncology and Immunology, having authored 34 papers that have together received 484 indexed citations. Recurring topics across this work include Circadian rhythm and melatonin (12 papers), Cancer Immunotherapy and Biomarkers (9 papers) and Immunotherapy and Immune Responses (4 papers). The work is most often cited by research in Endocrine and Autonomic Systems (125 citations), Biological Psychiatry (31 citations) and Immunology (128 citations). P. Lissoni has collaborated with scholars based in Italy, Switzerland and United States. Frequent co-authors include Gabriele Tancini, Sandro Barni, Franco Rovelli, S. Barni, Luca Fumagalli, Fabio Malugani, F Brivio, G Gardani, Ario Conti and E. Tisi. Their work appears in journals such as Cancer, Cancer Research and European Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.